Skip to main content
. 2017 Mar 24;1(5):385–395. doi: 10.1210/js.2017-00081

Table 1.

Characteristics of Patients With T1D

Type 1 Diabetes Autoantibodies
Case ID Age, y Sex BMI, kg/m2 GADA Result IA 2A Result MIAA Result Zn T8A Result Total Positive Autoantibody Count Duration of Diabetes, y Insulin Status
1 6062 10.7 M 21.9 N/A N/A N/A N/A N/A 6 No insulin
2 6063 4.4 M 23.8 + 1 3 No insulin
3 6064 19.6 F 22.6 + + + 3 9 No insulin
4 6089 14.3 M 26 + 1 8 No insulin
5 6083 15.2 F 18.4 + 1 11 No insulin
6 6087 17.5 M 21.9 + + 2 4 No insulin
7 6145 18 M 23.1 + + + 3 11 No insulin
8 6148 17.1 M 23.9 + + 2 7 No insulin
9 6261 16 M 20.7 + + 2 14 No insulin
10 6360 4.8 F 26.1 + 1 2.5 No insulin
11 6046 18.8 F 25.2 + + 2 8 Abundant insulin+ islets
12 6049 15 F 20.8 + + 2 10 Rare insulin + cells
13 6084 14.2 M 26.3 + 1 4 Some insulin+ cells in islets, patchy
14 6195 19.2 M 23.7 + + + + 4 5 Rare insulin + cells
15 6243 13 M 21.3 + 1 5 Abundant insulin+ islets
16 6265 11 M 12.9 + + 2 8 Rare insulin + cells
17 6268 12 F 26.6 + 1 3 Rare insulin + cells
18 6306 19 M 24.5 + 1 5 Abundant insulin+ islets
19 6342 14 F 24.3 + + 2 2 Abundant insulin+ islets
Mean 14.9 22.8
SEM 0.9 0.8

Abbreviations: +, positive; −, negative; F, female; GADA, glutamic acid decarboxylase; IA 2A, IA-2 antibody; M, male; MIAA, micro insulin autoantibody; N/A, not applicable; SEM, standard error of the mean; Zn T8A, zinc transporter antibody.